2026 NPPES data Dermatology Physician NPI 1295720910
Verify on CMS →

MARY ANN BENTZ

Dermatology Physician in WATERFORD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 544 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$205.91
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARY ANN BENTZ is a Dermatology Physician ([object Object]) practicing in WATERFORD, Connecticut with a Medicare Part D prescribing footprint of 2K claims across 544 beneficiaries — 12% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $205.91 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARY ANN BENTZ reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 1,713 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARY ANN BENTZ practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARY ANN BENTZ at a glance

Below national average

NPI registry status

Active

Issued 09/19/2005

NPI 1295720910

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,713 135% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Connecticut

How Dermatology Physician compares to other specialties among Connecticut providers

Connecticut providers

Dermatology Physician share within Connecticut

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Connecticut

Medicare quality performance — MIPS

MARY ANN BENTZ's 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARY ANN BENTZ is a Dermatology Physician provider practicing in WATERFORD, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1295720910. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARY ANN BENTZ appears in the CMS NPPES registry as a Dermatology Physician provider at 914 HARTFORD TPKE STE 103, WATERFORD, CT, 06385, with a listed phone of (860) 442-1346. NPI 1295720910 was issued on 09/19/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BENTZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,713 prescription claims written by this provider, covering 544 Medicare beneficiaries and totaling roughly $982K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

914 HARTFORD TPKE STE 103
WATERFORD, CT 06385

Provider Details

NPI 1295720910
Specialty Dermatology Physician
Gender Female
NPI Issued 09/19/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARY ANN BENTZ. Source: openpaymentsdata.cms.gov.

Total received

$206

Largest payer

Janssen Biotech, Inc.

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARY ANN BENTZ — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 1,713 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,713
Total Claims
$982K
Total Drug Cost
544
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,011
Total Day Supply
52,143
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$903K
Generic Drug Cost
$79K
Antibiotic Claims
164

Patient Demographics

Average Patient Age
74.9 years
Avg HCC Risk Score
1.14
Gender Split
64% female / 36% male
Age Distribution
<65: 25, 65-74: 246, 75-84: 201, 85+: 72

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Triamcinolone Acetonide
213
Clobetasol Propionate
145
Ketoconazole
104
Metronidazole
95
Mupirocin
93
Doxycycline Monohydrate
81
Valacyclovir
Valacyclovir Hcl
75
Nystatin
57
Halobetasol Propionate
54
Cephalexin
53

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARY ANN BENTZ fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARY ANN BENTZ's 1,713 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as BENTZ.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARY ANN BENTZ's specialty?
MARY ANN BENTZ specializes in Dermatology Physician and practices in WATERFORD, Connecticut.
How much does MARY ANN BENTZ prescribe under Medicare Part D?
In 2023, MARY ANN BENTZ wrote 1,713 Medicare Part D claims totaling $982K in drug costs for 544 beneficiaries.
What is MARY ANN BENTZ's Medicare quality score?
MARY ANN BENTZ has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARY ANN BENTZ located?
MARY ANN BENTZ is located at 914 HARTFORD TPKE STE 103, WATERFORD, CT, 06385. Phone: (860) 442-1346.
What is MARY ANN BENTZ's NPI number?
MARY ANN BENTZ's National Provider Identifier (NPI) is 1295720910, issued on 09/19/2005.
Does MARY ANN BENTZ prescribe more brand-name or generic drugs?
MARY ANN BENTZ's prescribing is 12% brand-name and 88% generic drugs by claim count, with $903K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARY ANN BENTZ prescribe most often?
Based on 2023 Medicare Part D data, MARY ANN BENTZ's most frequently prescribed drugs include Triamcinolone Acetonide, Clobetasol Propionate, Ketoconazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARY ANN BENTZ accept Medicare?
MARY ANN BENTZ appears in CMS Medicare data with 1,713 Part D claims and 544 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARY ANN BENTZ's credentials?
MARY ANN BENTZ's NPI is 1295720910. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology